In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Tze-Fan Chao
Speaker
Tze-Fan Chao
Tze-Fan Chao Tze-Fan Chao

Taipei Veterans General Hospital, Taipei (Taiwan)

Speciality : Arrhythmias-General

Tze-Fan Chao is an Associate Professor at National Yang-Ming University and attending physician at the Division of Cardiology, Taipei Veterans General Hospital, Taiwan. Dr Chao’s main clinical interest is device implantation. His research interests are in the areas of atrial fibrillation, including epidemiology, stroke risk stratification and oral anticoagulants for stroke prevention. He has published more than 60 original articles as first, co-first or corresponding author in SCI journals including Circulation, JACC, European Heart Journal, Stroke, Chest, Heart, Mayo Clinic Proceedings, Heart Rhythm, and etc. Currently, he is the chair of the APHRS practical guideline subcommittee and section editor of “Thrombosis and Haemostasis”. He is also a reviewer for several international journals, including Circulation, JACC, EHJ, and etc. He has been invited to give presentations at important international conferences, including AHA, ACC, ESC, and etc.

42 presentations from this speaker

Oral anticoagulants in extremely high risk very elderly (>90 years) patients with Atrial Fibrillation

Event : ESC Congress 2020

  • Session : Oral Anticoagulant Therapy in the Elderly with Atrial Fibrillation
  • Speaker : T Chao (Taipei,TW)

Recommended and non-recommended edoxaban dosing in patients with atrial fibrillation (AF): one-year clinical events from the Global ETNA-AF non-interventional study (NIS)

Event : ESC Congress 2020

  • Session : Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation in ‘Special’ Situations
  • Speaker : T Chao (Taipei,TW)

Risks and outcomes of gastrointestinal malignancies in anticoagulated atrial fibrillation patients experiencing gastrointestinal bleeding

Event : ESC Congress 2020

  • Session : Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation in ‘Special’ Situations
  • Speaker : T Chao (Taipei,TW)

Comparisons of direct oral anticoagulants and warfarin in patients with atrial fibrillation and liver cirrhosis

Event : ESC Congress 2019

  • Session : Atrial fibrillation and oral anticoagulation 5
  • Speaker : T Chao (Taipei,TW)

Use of direct oral anticoagulants in patients with atrial fibrillation having a history of intracranial hemorrhage

Event : ESC Congress 2019

  • Session : Atrial fibrillation and oral anticoagulation 5
  • Speaker : T Chao (Taipei,TW)

A patient with atrial fibrillation and end-stage renal failure.

Event : ESC Congress 2018

  • Session : Difficult anticoagulation management in atrial fibrillation: a case-based approach
  • Speaker : T Chao (Taipei,TW)

Off-label dosing of non-vitamin K antagonist oral anticoagulants and adverse outcomes in the daily practice

Event : ESC Congress 2018

  • Session : Atrial fibrillation - Stroke prevention 3
  • Speaker : T Chao (Taipei,TW)

Lifetime risks, projected numbers and adverse outcomes in asian patients with atrial fibrillation

Event : ESC Congress 2017

  • Session : Demographics and screening
  • Speaker : T Chao (Taipei,TW)

Patients with recent intracranial or gastrointestinal bleeds.

Event : ESC Congress 2017

  • Session : Stroke prevention in atrial fibrillation: the known knowns and the known unknowns
  • Speaker : T Chao (Taipei,TW)

Risk and predictors of malignancy in patients with atrial fibrillation: a nationwide population-based Study

Event : ESC Congress 2017

  • Session : Best Posters in risk prediction and atrial fibrillation
  • Speaker : T Chao (Taipei,TW)

The results of screen of atrial fibrillation event in Taiwan: the SAFE-Taiwan study

Event : EHRA 2017

  • Session : Atrial Fibrillation - Clinical and epidemiological aspects
  • Speaker : T Chao (Taipei,TW)

The impact of atrial fibrillation on risk of recurrence and mortality among patients with venous thromboembolism

Event : ESC Congress 2016

  • Session : Comorbidities and atrial fibrillation
  • Speaker : T Chao (Taipei,TW)

Validation of a Modified CHA2DS2-VASc score for stroke risk Stratification in Asian patients with qtrial fibrillation

Event : ESC Congress 2016

  • Session : Antithrombotic therapy in atrial fibrillation 2
  • Speaker : T Chao (Taipei,TW)

The association between influenza infection, vaccination and atrial fibrillation: a nationwide case-control study

Event : ESC Congress 2015

  • Session : Atrial fibrillation population based studies
  • Speaker : T Chao (Taipei,TW)

The relationship between cold temperature and risk of ischemic stroke in patients with atrial fibrillation

Event : ESC Congress 2015

  • Session : Registry I - Atrial fibrillation
  • Speaker : T Chao (Taipei,TW)

Risk of acute myocardial infarction in patients with atrial fibrillation having a CHA2DS2-VASc score of 0 or 1

Event : ESC Congress 2014

  • Session : Clinical outcomes in atrial fibrillation III
  • Speaker : T Chao (Taipei,TW)

Risk of Ischemic Stroke for Male Patients with Atrial Fibrillation with a CHA2DS2-VASc Score of 1

Event : ESC Congress 2014

  • Session : Registry Hot Line: Atrial fibrillation and myocardial infarction
  • Speaker : T Chao (Taipei,TW)

Using the CHA2DS2-VASc Score for refining stroke risk stratification in low-risk Asian patients (ATRIA Score 0-5) with atrial fibrillation

Event : ESC Congress 2014

  • Session : Risk assessment in atrial fibrillation: what really matters?
  • Speaker : T Chao (Taipei,TW)

Hyperuricemia and the risk of ischemic stroke in patients with atrial fibrillation

Event : ESC Congress 2013

  • Session : Atrial fibrillation
  • Speaker : T Chao (Taipei,TW)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are